Skip to content
The Nexus
DossierENTITY

megadeal

Coverage of megadeal in the Nexus archive.

Earliest in view: Aug 4 · 04:00 UTCMost recent: Aug 4 · 04:00 UTC
Co-mentioned in this coverage
AstraZenecaorganization1Bristol Myers Squibborganization1Big Pharmatopic1drugmakertopic1
Recent coverage
  • BUSINESSAug 4 · 04:00 UTCFINANCIAL TIMES WORLD
    The $400bn megadeal brewing in big pharma

    AstraZeneca and Bristol Myers Squibb are in talks that could result in a $400bn merger, creating the world’s fourth-largest drugmaker by market value.

megadeal · Dossier · The Nexus